Our associated Hospitals sites having GMP manufacturing facility for your development batches of CAR T, Gene therapy, etc. Very unique state of art facility in Washinton DC with patient pool for going with proof of concept or pilot clinical studies.
Below are cell therapy development facility set-up in development at USA and India and soon to provide full services.
Our GMP manufacturing facility is purpose-built for advanced cell therapy production, ensuring compliance with FDA, EMA, and global GMP guidelines. We offer flexible, modular cleanroom suites for autologous and allogeneic CAR-T cell therapies, enabling rapid adaptation to your project needs.
All processes follow stringent electronic batch record documentation (eBMR) and full traceability systems.
Scalability: From early-phase patient-specific batches to commercial-scale readiness, our flexible setup can grow with your clinical trial or commercialization plan.
We provide comprehensive clinical trial collaboration services with leading hospitals, academic centers, and specialized oncology institutions across the United States and India to support CAR-T cell therapy development from early-phase clinical trials to commercial deployment.
Partnerships with NCI-designated Cancer Centers, transplant centers, and top academic medical institutions renowned for pioneering CAR-T clinical research.
Collaborations with premier oncology hospitals, government medical institutions, and clinical research networks experienced in cell therapy trials.
These strategic alliances ensure that patients, clinicians, and trial sponsors benefit from seamless coordination between manufacturing, logistics, and clinical care.
Partnerships with hospitals prepared for commercial CAR-T infusions. Reimbursement strategy planning with hospitals for Medicare/Medicaid and private payers. Integration with CAR-T Centers of Excellence to support standard-of-care adoption post-approval.
Collaborations with leading cancer centers to establish CAR-T infusion units. Guidance on regulatory submissions with CDSCO (Central Drugs Standard Control Organization) and obtaining marketing authorization. Establishment of treatment pathways and pricing strategies tailored for the Indian healthcare ecosystem.
✅ Bi-continental Expertise (USA & India)
✅ Established Hospital Networks for Oncology & Hematology
✅ End-to-End Control of Cell Therapy Value Chain
✅ Commercial Scalability from clinical studies to market introduction
Bring Your CAR-T Therapy to Patients — Faster, Safer, and Globally Aligned.
Partner with us to build the future of personalized cancer care
We worked with the client’s R&D team to optimize their CAR-T production process, transitioning from academic protocols to automated, closed GMP-compatible systems. Using platforms such as CliniMACS Prodigy® and Sepax®, we reduced process variability by over 30%.
Whether you’re developing next-generation therapies, optimizing your product pipeline, or scaling pharmaceutical operations—Endra Pharma is your trusted partner from strategy to supply.
Endra Pharma is USA based B2B services company having global partner network along with owned CDMO, CRO services and Lab network addressing need in product development.